Literature DB >> 6872961

Propylthiouracil (PTU) pharmacology in the rat. II. Effects of PTU on thyroid function.

D S Cooper, J D Kieffer, R Halpern, V Saxe, H Mover, F Maloof, E C Ridgway.   

Abstract

Using a sensitive and specific RIA for propylthiouracil (PTU), we examined the effects of short term (1 week) and long term (1 month) PTU treatment on thyroid function in the rat, and correlated changes in thyroid function with serum and thyroid PTU levels. After 1 week, dose-dependent decreases in thyroid PBI, serum T4, and serum T3 were observed, with concomitant elevations in the serum rT3 to T4 ratio and serum TSH. Fifty percent suppression of thyroid PBI occurred at a PTU concentration in the drinking water of 0.0005% (ED50), with concomitant serum and thyroid PTU levels of 0.3 micrograms/ml and 300 ng/thyroid, respectively. After 1 month of PTU, serum T4 values were lower than after 1 week of treatment for all PTU concentrations, but values for the other thyroid functional variables were similar to those in the 1 week group at comparable PTU dosage. The PTU dose-response curve for thyroid PBI was similar to that seen after 1 week of treatment, with an ED50 of 0.0004%. After discontinuation of PTU treatment, PTU disappeared from serum in a biexponential fashion, with an early rapid distribution phase (t 1/2 = approximately 4 h) and a second slower elimination phase (t 1/2 = approximately 2.6 days). In the thyroid, an initial increase in PTU content was seen up to 18 h after PTU withdrawal; thereafter, thyroid PTU declined linearly, with a t 1/2 of 1.4 days in both groups. After PTU withdrawal, thyroid PBI recovered with a t 1/2 of 1.09 days after 1 week on PTU, but recovery was prolonged (t 1/2 = 2.8 days) after 1 month of treatment. Log thyroid PTU and log thyroid PBI were linearly related after PTU withdrawal (r = 0.97; P less than 0.001) after 1 week but not after 1 month. Serum T4 and serum T3 remained below control values for 2 days, but then rapidly normalized, with T3 values rising transiently above the control value. This rebound occurred at a time when PTU was still present within the thyroid, before thyroid PBI had returned to baseline. These data indicate a close inverse relationship between PTU dose and both thyroid hormone biosynthesis and peripheral T4 deiodination. In addition, short and long term PTU treatments have quantitatively similar effects on thyroid function, although recovery of thyroid function is prolonged after long term treatment. The biexponential disappearance of PTU from the serum is compatible with a two-compartment model of PTU distribution. The early increase in thyroid PTU after drug withdrawal is suggestive of an inhibitory effect of PTU upon its own uptake by the thyroid, whereas the faster disappearance of PTU from the thyroid than from serum is consistent with intrathyroid drug metabolism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6872961     DOI: 10.1210/endo-113-3-921

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  Polybrominated diphenyl ether (DE-71) interferes with thyroid hormone action independent of effects on circulating levels of thyroid hormone in male rats.

Authors:  Ruby Bansal; Daniel Tighe; Amin Danai; Dorothea F K Rawn; Dean W Gaertner; Doug L Arnold; Mary E Gilbert; R Thomas Zoeller
Journal:  Endocrinology       Date:  2014-07-25       Impact factor: 4.736

2.  Estimating Margin of Exposure to Thyroid Peroxidase Inhibitors Using High-Throughput in vitro Data, High-Throughput Exposure Modeling, and Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling.

Authors:  Jeremy A Leonard; Yu-Mei Tan; Mary Gilbert; Kristin Isaacs; Hisham El-Masri
Journal:  Toxicol Sci       Date:  2016-02-10       Impact factor: 4.849

3.  Adult-Onset Hypothyroidism Alters the Metaplastic Properties of Dentate Granule Cells by Decreasing Akt Phosphorylation.

Authors:  Marwa Yousef; Ercan Babür; Sumeyra Delibaş; Burak Tan; Ayşenur Çimen; Nurcan Dursun; Cem Süer
Journal:  J Mol Neurosci       Date:  2019-05-09       Impact factor: 3.444

4.  Potentiation of glucose-induced insulin release by thiourea and thiourea derivatives.

Authors:  H P Ammon; M C Melien; T Pfäffle
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

5.  Effects of amiodarone and thyroid dysfunction on myocardial calcium, serum calcium and thyroid hormones in the rat.

Authors:  M D Gammage; J A Franklyn; S D Logan
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

6.  Restoration of cardiac tissue thyroid hormone status in experimental hypothyroidism: a dose-response study in female rats.

Authors:  Nathan Y Weltman; Kaie Ojamaa; Olga V Savinova; Yue-Feng Chen; Evelyn H Schlenker; Riccardo Zucchi; Alessandro Saba; Daria Colligiani; Christine J Pol; A Martin Gerdes
Journal:  Endocrinology       Date:  2013-04-17       Impact factor: 4.736

7.  Dog thyroid glands after chronic administration of antithyroid drugs.

Authors:  Y Kameda
Journal:  Am J Pathol       Date:  1984-11       Impact factor: 4.307

8.  Extrapolating In Vitro Screening Assay Data for Thyroperoxidase Inhibition to Predict Serum Thyroid Hormones in the Rat.

Authors:  Iman Hassan; Hisham El-Masri; Jermaine Ford; Amanda Brennan; Sakshi Handa; Katie Paul Friedman; Mary E Gilbert
Journal:  Toxicol Sci       Date:  2020-02-01       Impact factor: 4.109

9.  Effects of Propyithiouracil (PTU) Administration on the Synthesis and Secretion of Thyroglobulin in the Rat Thyroid Gland: A Quantitative Immuno-electron Microscopic Study Using Immunogold Technique.

Authors:  Xue Yi; Koichi Yamamoto; Lu Shu; Ryohei Katoh; Akira Kawaoi
Journal:  Endocr Pathol       Date:  1997       Impact factor: 4.056

10.  Mechanistic Computational Model for Extrapolating In Vitro Thyroid Peroxidase (TPO) Inhibition Data to Predict Serum Thyroid Hormone Levels in Rats.

Authors:  Sakshi Handa; Iman Hassan; Mary Gilbert; Hisham El-Masri
Journal:  Toxicol Sci       Date:  2021-08-30       Impact factor: 4.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.